Skip to content

Force controlled coronavirus (COVID-19) swab study

Force controlled coronavirus (COVID-19) swab study - FCCSS

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
DRKS
Registry ID
DRKS00024455
Enrollment
80
Registered
2021-02-09
Start date
2021-02-21
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

U07.1

Interventions

Group 1: swab by force 1 Group 2: swab by force 2 Group 3: swab by force 3 Group 4: nasopharyngeal swab (NPS)

Sponsors

Universitätsklinik Leipzig
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: positive SARS-CoV2 Test, agree to the ICF

Exclusion criteria

Exclusion criteria: Age<18, pregnant, breastfeeding women, cancer or malformation in nose or throat

Design outcomes

Primary

MeasureTime frame
The aim is to show that a higher force during a SARS CoV 2 Swab results in lower cycle threshold of a PCR.

Secondary

MeasureTime frame
The secondary outcome ist to show a possible reduction of false negative SARS CoV 2 PCR tests by using a higher force in a SARS CoV 2 swab.

Countries

Germany

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 7, 2026